Evidence map›Paper›PMID 31652543›Full record

ReviewNutrients2019

Improving Health-Promoting Effects of Food-Derived Bioactive Peptides through Rational Design and Oral Delivery Strategies.

Paloma Manzanares, Mónica Gandía, Sandra Garrigues, Jose F Marcos

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Special Issue: "Rational Design and Synthesis of Bioactive Molecules".International journal of molecular sciences · 2024
    Article
  11. Article
  12. Review
  13. Recent advances in the development of therapeutic peptides.Trends in pharmacological sciences · 2023
    Review
  14. Food Peptides for the Nutricosmetic Industry.Antioxidants (Basel, Switzerland) · 2023
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paloma ManzanaresDepartment of Biotechnology, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Consejo Superior de Investigaciones Científicas (CSIC), 46980 Paterna, Valencia, Spain. pmanz@iata.csic.es.
Mónica GandíaDepartment of Biotechnology, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Consejo Superior de Investigaciones Científicas (CSIC), 46980 Paterna, Valencia, Spain. mgandia@iata.csic.es.
Sandra GarriguesDepartment of Biotechnology, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Consejo Superior de Investigaciones Científicas (CSIC), 46980 Paterna, Valencia, Spain. sgarrigues@iata.csic.es.ORCID 0000-0002-4104-6246
Jose F MarcosDepartment of Biotechnology, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Consejo Superior de Investigaciones Científicas (CSIC), 46980 Paterna, Valencia, Spain. jmarcos@iata.csic.es.ORCID 0000-0003-3339-2584
Consejo Superior de Investigaciones Científicas · ES

Funding

ANTISENSE INHIBITION OF MULTIDRUG RESISTANCE IN CANCERR41CA068790 · NCI · ISIS PHARMACEUTICALS, INC. · PI DEAN, NICHOLAS M · 1995 to 1995
–
Generalitat Valenciana PROMETEO/2018/066Ministerio de Ciencia, Innovación y Universidades BIO2015-68790-C2-1-RMinisterio de Ciencia, Innovación y Universidades RTI2018-101115-B-C2-1Ministerio de Educación, Cultura y Deporte FPU13/04584
6 · The paper itself

Abstract

Over the last few decades, scientific interest in food-derived bioactive peptides has grown as an alternative to pharmacological treatments in the control of lifestyle-associated diseases, which represent a serious health problem worldwide. Interest has been directed towards the control of hypertension, the management of type 2 diabetes and oxidative stress. Many food-derived antihypertensive peptides act primarily by inhibiting angiotensin I-converting enzyme (ACE), and to a lesser extent, renin enzyme activities. Antidiabetic peptides mainly inhibit dipeptidyl peptidase-IV (DPP-IV) activity, whereas antioxidant peptides act through inactivation of reactive oxygen species, free radicals scavenging, chelation of pro-oxidative transition metals and promoting the activities of intracellular antioxidant enzymes. However, food-derived bioactive peptides have intrinsic weaknesses, including poor chemical and physical stability and a short circulating plasma half-life that must be addressed for their application as nutraceuticals or in functional foods. This review summarizes the application of common pharmaceutical approaches such as rational design and oral delivery strategies to improve the health-promoting effects of food-derived bioactive peptides. We review the structural requirements of antihypertensive, antidiabetic and antioxidant peptides established by integrated computational methods and provide relevant examples of effective oral delivery systems to enhance solubility, stability and permeability of bioactive peptides.

Indexed as

Dietary SupplementsFunctional FoodPeptidesAdministration, OralAntioxidantsDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsHealth PromotionHumansHypertensionOxidative StressAntioxidantsDipeptidyl-Peptidase IV InhibitorsPeptidescomputational methodsfood-derived bioactive peptidesfunctional foodshypertensionnutraceuticalsoral delivery strategiesoxidative stressrationally designed peptidesstructural requirementstype 2 diabetes

Identifiers

PMID31652543
PMCPMC6836114
OpenAlexW2982199488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.